Young H A, Hardy K J
Cellular and Molecular Immunology Section, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
J Leukoc Biol. 1995 Oct;58(4):373-81.
In 1965 Wheelock reported that phytohemagglutinin could induce from human leukocytes an interferon-like virus inhibitor [1]. This substance, which turned out to be interferon-gamma (IFN-gamma), has been the subject, directly or indirectly, of thousands of scientific publications since that initial report. Past research has led to the general conclusion that IFN-gamma is much more than an interferon in that it has broader effects on the various arms of the immune system than most any other lymphokine or cytokine. In this review we discuss the effects of IFN-gamma on the various cell lineages of the immune system, focusing on the biology of its actions. In addition, we summarize research focused on the consequences of introducing IFN-gamma cDNA into tumor cells, aberrant IFN-gamma production in transgenic animals, and inhibition of IFN-gamma effects by knocking out either the IFN-gamma gene itself or the IFN-gamma receptor gene.
1965年,惠洛克报告称,植物血凝素可诱导人白细胞产生一种干扰素样病毒抑制剂[1]。事实证明,这种物质就是γ干扰素(IFN-γ),自最初的报告以来,它直接或间接地成为了数千篇科学出版物的主题。过去的研究得出了一个普遍结论,即IFN-γ远不止是一种干扰素,因为它对免疫系统各部分的影响比大多数其他淋巴因子或细胞因子更为广泛。在这篇综述中,我们讨论了IFN-γ对免疫系统各种细胞谱系的影响,重点关注其作用生物学。此外,我们总结了有关将IFN-γ cDNA导入肿瘤细胞的后果、转基因动物中异常产生IFN-γ以及通过敲除IFN-γ基因本身或IFN-γ受体基因来抑制IFN-γ作用的研究。